US-based health technology company Anumana has partnered with AliveCor for the development of its AI algorithms intended for ...
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices
conditions affecting the heart muscle (cardiomyopathies and myocarditis). Around 920,000 people in the UK were living with heart failure in 2018 with an estimated 200,000 new diagnoses each year.
Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...
NICE has given the go-ahead for the use of two algorithms, HeartLogic and TriageHF, in cardiac implantable electronic devices (CIEDs) to alert remote healthcare professionals to suspected worsening of ...
Please provide your email address to receive an email when new articles are posted on . Device-based therapy may be necessary for certain patients with NYHA class II/III heart failure with reduced ...
New study presented at HRX Live 2025 demonstrates continued advancement of company’s AI program HeartBeam's AI algorithm performed equally well on HeartBeam 3D ECG system and standard 12L ECGs in ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has signed an exclusive agreement with University of ...
For the fourth time in half as many years, Anumana has earned the FDA’s breakthrough device designation for another of its artificial intelligence algorithms designed to catch hard-to-spot heart ...
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices
The diagnostics advisory committee looked at evidence on algorithm-based remote monitoring of heart failure in people with cardiac implantable electronic devices (CIEDs). Evidence was considered from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback